Recent Activity

Loading...

PBE

Invesco Biotechnology & Genome ETF · PSE

  • Category Equity
  • Expense Ratio 0.58%
  • Listing Date Jun 23, 2005
  • Volume 9,232.0
  • Market Cap (AUM) $259.18M

Performance

+4.43%

1W

+2.11%

1M

-0.81%

3M

+15.29%

6M

-2.52%

YTD

+3.14%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Bio-Techne CorporationTECH5.41%
  • Neurocrine Biosciences, Inc.NBIX5.30%
  • Regeneron Pharmaceuticals, Inc.REGN4.98%
  • Amgen Inc.AMGN4.94%
  • Biogen Inc.BIIB4.90%
  • Vertex Pharmaceuticals IncorporatedVRTX4.79%
  • BioMarin Pharmaceutical Inc.BMRN4.75%
  • Gilead Sciences, Inc.GILD4.56%
  • PTC Therapeutics, Inc.PTCT3.55%
  • TG Therapeutics, Inc.TGTX3.41%

Technical Analysis of PBE 2024-05-03

Overview:

In analyzing the provided Technical Analysis (TA) data for PBE over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to forecast the possible stock price movement in the upcoming days. By examining these key indicators, we aim to provide a comprehensive and insightful prediction for the future ...

See more ...

Recent News & Updates